Protea

Protea Vaccine Technologies Ltd.

corporate_fareorganization

Web page: http://www.meytavti.co.il

Country: Israel

Protea

- Funding / Projects
  (1)

1 Projects, page 1 of 1

CAREPNEUMO (Combating Antibiotics Resistant Pneumococci by Novel Strategies Based on in vivo and in vitro Host – Pathogen Interactions)
assignment_turned_inProject2009 - 2012Partners:IPGMER, Protea, UMH, INSTITUTO DE MEDICINA MOLECULAR, Helmholtz Association of German Research Centres +9 partners
IPGMER,
Protea,
UMH,
INSTITUTO DE MEDICINA MOLECULAR,
Helmholtz Association of German Research Centres,
University of Glasgow,
CISPA,
University of Greifswald,
CSIC,
USB,
HOSPITAL DE PEDIATRIA SAMIC PROF. DR. JUAN P. GARRAHAN,
NIL,
UKA,
UoA
Funder: European Commission Project Code: 223111
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
<script type="text/javascript">  </script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

Protea

Protea

1 Projects, page 1 of 1

CAREPNEUMO (Combating Antibiotics Resistant Pneumococci by Novel Strategies Based on in vivo and in vitro Host – Pathogen Interactions)

Loading